Shadi Abdar Esfahani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 5 | 2022 | 2090 | 1.020 |
Why?
|
Stomach Neoplasms | 2 | 2022 | 1330 | 0.860 |
Why?
|
Organometallic Compounds | 1 | 2023 | 659 | 0.680 |
Why?
|
Nuclear Medicine | 1 | 2021 | 230 | 0.640 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 595 | 0.580 |
Why?
|
Radiation Oncology | 2 | 2022 | 552 | 0.560 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2009 | 0.480 |
Why?
|
Anal Canal | 2 | 2014 | 376 | 0.460 |
Why?
|
Myoblasts, Skeletal | 1 | 2014 | 76 | 0.460 |
Why?
|
Household Articles | 1 | 2012 | 24 | 0.440 |
Why?
|
Cell Tracking | 1 | 2014 | 144 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 572 | 0.420 |
Why?
|
Ureterocele | 1 | 2011 | 28 | 0.420 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 319 | 0.410 |
Why?
|
Leadership | 1 | 2021 | 1357 | 0.410 |
Why?
|
Dextrans | 1 | 2014 | 597 | 0.410 |
Why?
|
Epispadias | 1 | 2011 | 18 | 0.400 |
Why?
|
Cardiac Tamponade | 1 | 2012 | 174 | 0.400 |
Why?
|
Cystoscopy | 1 | 2011 | 133 | 0.390 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2012 | 165 | 0.380 |
Why?
|
Pericardium | 2 | 2012 | 667 | 0.380 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 106 | 0.380 |
Why?
|
Heart Injuries | 1 | 2012 | 209 | 0.370 |
Why?
|
Wounds, Penetrating | 1 | 2012 | 307 | 0.370 |
Why?
|
Bladder Exstrophy | 1 | 2011 | 107 | 0.360 |
Why?
|
Myoblasts | 1 | 2011 | 239 | 0.360 |
Why?
|
Urinary Bladder | 2 | 2012 | 1174 | 0.320 |
Why?
|
Urinary Incontinence | 1 | 2011 | 496 | 0.290 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 386 | 0.280 |
Why?
|
Gallium Radioisotopes | 2 | 2023 | 178 | 0.270 |
Why?
|
Spinal Cord Injuries | 1 | 2012 | 930 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2220 | 0.240 |
Why?
|
Infant, Newborn, Diseases | 1 | 2009 | 585 | 0.230 |
Why?
|
Radiography | 3 | 2022 | 7019 | 0.230 |
Why?
|
Positron-Emission Tomography | 7 | 2022 | 6184 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 6 | 2022 | 35300 | 0.220 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.210 |
Why?
|
Octreotide | 1 | 2023 | 146 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.210 |
Why?
|
Prenatal Diagnosis | 1 | 2009 | 1240 | 0.210 |
Why?
|
Hexokinase | 1 | 2022 | 125 | 0.200 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 193 | 0.200 |
Why?
|
Granzymes | 1 | 2023 | 271 | 0.200 |
Why?
|
Receptors, Peptide | 1 | 2023 | 273 | 0.200 |
Why?
|
Receptor, erbB-3 | 1 | 2022 | 142 | 0.200 |
Why?
|
Family Leave | 1 | 2021 | 18 | 0.200 |
Why?
|
Lactates | 1 | 2022 | 432 | 0.190 |
Why?
|
Pyruvic Acid | 1 | 2022 | 196 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8279 | 0.190 |
Why?
|
Mice, Nude | 4 | 2022 | 3658 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4250 | 0.190 |
Why?
|
Organizations | 1 | 2021 | 170 | 0.180 |
Why?
|
Sick Leave | 1 | 2021 | 110 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.180 |
Why?
|
CA-19-9 Antigen | 2 | 2010 | 110 | 0.180 |
Why?
|
Disease Models, Animal | 5 | 2016 | 17981 | 0.170 |
Why?
|
Heart | 1 | 2012 | 4423 | 0.170 |
Why?
|
Kidney Pelvis | 2 | 2010 | 187 | 0.170 |
Why?
|
Lung Injury | 1 | 2023 | 432 | 0.160 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1874 | 0.160 |
Why?
|
Ureteral Obstruction | 2 | 2010 | 295 | 0.160 |
Why?
|
Kidney | 1 | 2013 | 7128 | 0.150 |
Why?
|
Policy | 1 | 2021 | 509 | 0.150 |
Why?
|
Internship and Residency | 3 | 2022 | 5787 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6756 | 0.140 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 2244 | 0.140 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 16618 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1180 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1839 | 0.140 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 576 | 0.130 |
Why?
|
Humans | 39 | 2023 | 743521 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 761 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 674 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2022 | 2449 | 0.130 |
Why?
|
Mice | 10 | 2023 | 80999 | 0.120 |
Why?
|
Animals | 16 | 2023 | 168434 | 0.120 |
Why?
|
Tissue Scaffolds | 2 | 2012 | 958 | 0.120 |
Why?
|
Rabbits | 4 | 2014 | 4892 | 0.120 |
Why?
|
Fluorine Radioisotopes | 1 | 2017 | 440 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2492 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 696 | 0.110 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 194 | 0.110 |
Why?
|
Cystostomy | 1 | 2012 | 26 | 0.110 |
Why?
|
Molecular Imaging | 2 | 2023 | 817 | 0.110 |
Why?
|
Matrix Metalloproteinases | 1 | 2015 | 391 | 0.100 |
Why?
|
Breast Feeding | 1 | 2020 | 1338 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 603 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3726 | 0.100 |
Why?
|
Gastric Outlet Obstruction | 1 | 2012 | 56 | 0.100 |
Why?
|
Play and Playthings | 1 | 2012 | 79 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 2012 | 202 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1185 | 0.100 |
Why?
|
Laminectomy | 1 | 2012 | 234 | 0.100 |
Why?
|
Tissue Engineering | 2 | 2012 | 1883 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2016 | 494 | 0.100 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6464 | 0.100 |
Why?
|
Histiocytosis | 1 | 2011 | 40 | 0.090 |
Why?
|
Urinary Bladder Diseases | 1 | 2011 | 167 | 0.090 |
Why?
|
Iron Overload | 1 | 2012 | 241 | 0.090 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2011 | 260 | 0.090 |
Why?
|
Ureter | 1 | 2013 | 375 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2010 | 85 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2013 | 423 | 0.090 |
Why?
|
Quality of Life | 1 | 2011 | 12832 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 224 | 0.090 |
Why?
|
Urodynamics | 1 | 2011 | 346 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 253 | 0.090 |
Why?
|
Genital Diseases, Male | 1 | 2010 | 84 | 0.090 |
Why?
|
Scrotum | 1 | 2010 | 116 | 0.090 |
Why?
|
Chondrocytes | 1 | 2015 | 803 | 0.090 |
Why?
|
Staining and Labeling | 1 | 2014 | 1100 | 0.090 |
Why?
|
Ferritins | 1 | 2012 | 587 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1601 | 0.080 |
Why?
|
Female | 17 | 2022 | 379875 | 0.080 |
Why?
|
Klinefelter Syndrome | 1 | 2009 | 49 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15514 | 0.080 |
Why?
|
Graves Disease | 1 | 2010 | 244 | 0.080 |
Why?
|
Hypospadias | 1 | 2009 | 92 | 0.080 |
Why?
|
Disorders of Sex Development | 1 | 2009 | 122 | 0.080 |
Why?
|
Fecal Incontinence | 1 | 2010 | 239 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 247 | 0.080 |
Why?
|
Graves Ophthalmopathy | 1 | 2009 | 117 | 0.080 |
Why?
|
Foreign Bodies | 1 | 2012 | 401 | 0.070 |
Why?
|
Estradiol | 1 | 2015 | 2025 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2172 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1920 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2122 | 0.070 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 407 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2016 | 63105 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1267 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1790 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 646 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1094 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5506 | 0.070 |
Why?
|
Infant | 6 | 2013 | 35059 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1586 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14676 | 0.060 |
Why?
|
United States | 3 | 2022 | 69834 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6730 | 0.060 |
Why?
|
Cytokines | 2 | 2010 | 7333 | 0.060 |
Why?
|
Child | 12 | 2012 | 77577 | 0.060 |
Why?
|
Contrast Media | 2 | 2017 | 5281 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1221 | 0.060 |
Why?
|
Male | 18 | 2022 | 349771 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2009 | 812 | 0.060 |
Why?
|
Neutropenia | 1 | 2009 | 895 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8911 | 0.060 |
Why?
|
Exercise Test | 1 | 2011 | 2073 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2016 | 3270 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2906 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3566 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2017 | 2328 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1619 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2431 | 0.050 |
Why?
|
Collagen Type I | 1 | 2023 | 594 | 0.050 |
Why?
|
Bioreactors | 2 | 2012 | 236 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 1505 | 0.050 |
Why?
|
Echocardiography | 1 | 2012 | 5078 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4564 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3304 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5976 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 411 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2914 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3532 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 563 | 0.040 |
Why?
|
Iran | 2 | 2011 | 704 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12950 | 0.040 |
Why?
|
Interleukin-12 | 2 | 2010 | 586 | 0.040 |
Why?
|
Radiology, Interventional | 1 | 2021 | 461 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.040 |
Why?
|
Rats | 1 | 2012 | 24202 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 403 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4890 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2678 | 0.030 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 64 | 0.030 |
Why?
|
Copper Radioisotopes | 1 | 2015 | 88 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11353 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1908 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 835 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19847 | 0.030 |
Why?
|
Pregnancy | 2 | 2020 | 29209 | 0.030 |
Why?
|
Adolescent | 5 | 2013 | 85757 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 541 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
Interleukin-2 | 2 | 2010 | 1904 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2010 | 25559 | 0.030 |
Why?
|
Menisci, Tibial | 1 | 2015 | 269 | 0.030 |
Why?
|
Chelation Therapy | 1 | 2012 | 66 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12919 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 239 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1829 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2627 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20130 | 0.030 |
Why?
|
Piebaldism | 1 | 2011 | 3 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 564 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2079 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3214 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17432 | 0.020 |
Why?
|
Child, Preschool | 5 | 2012 | 40911 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2116 | 0.020 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 318 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 534 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2379 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6453 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40012 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4176 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 408 | 0.020 |
Why?
|
Pigmentation Disorders | 1 | 2011 | 100 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13647 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15280 | 0.020 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2010 | 75 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2010 | 3203 | 0.020 |
Why?
|
Urothelium | 1 | 2012 | 277 | 0.020 |
Why?
|
Brain | 1 | 2016 | 26303 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 720 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2015 | 970 | 0.020 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 35 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 813 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3141 | 0.020 |
Why?
|
Antigens, CD20 | 1 | 2009 | 198 | 0.020 |
Why?
|
Body Fluids | 1 | 2010 | 319 | 0.020 |
Why?
|
Manometry | 1 | 2010 | 445 | 0.020 |
Why?
|
Quinolines | 1 | 2013 | 729 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4410 | 0.020 |
Why?
|
Oral Ulcer | 1 | 2009 | 95 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1180 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1736 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13249 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8305 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20723 | 0.020 |
Why?
|
Biofilms | 1 | 2012 | 619 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 19213 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2011 | 545 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2009 | 458 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3603 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1206 | 0.020 |
Why?
|
Consanguinity | 1 | 2009 | 456 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1970 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2009 | 451 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.020 |
Why?
|
Neprilysin | 1 | 2009 | 440 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2016 | 1432 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1520 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
Candidiasis | 1 | 2009 | 365 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1520 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2457 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3501 | 0.020 |
Why?
|
Electromyography | 1 | 2010 | 1376 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9864 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3881 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1549 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4541 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2009 | 1872 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 844 | 0.020 |
Why?
|
Neoplasms | 1 | 2013 | 21670 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2093 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15046 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4209 | 0.010 |
Why?
|
Abdomen | 1 | 2010 | 1116 | 0.010 |
Why?
|
Rare Diseases | 1 | 2009 | 559 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2009 | 1177 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2926 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 77457 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 56410 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1485 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9370 | 0.010 |
Why?
|
Adult | 4 | 2022 | 213870 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6159 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3585 | 0.010 |
Why?
|
Hepatitis C | 1 | 2012 | 1585 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2010 | 21723 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 1414 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3706 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5065 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4031 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4327 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39047 | 0.010 |
Why?
|
Middle Aged | 2 | 2022 | 213185 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9693 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 72325 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57739 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11499 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16338 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11464 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25058 | 0.010 |
Why?
|
Aged | 1 | 2020 | 163137 | 0.000 |
Why?
|
Risk Assessment | 1 | 2009 | 23346 | 0.000 |
Why?
|
Mutation | 1 | 2009 | 29701 | 0.000 |
Why?
|